Synergistic diagnostic value of circulating tumor cells and tumor markers CEA/CA19-9 in colorectal cancer

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Boursi B, Arber N. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr Pharm Des. 2007;13(22):2274–2282.
   PubMed Web of Science ®Google Scholar
• Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–717.
   PubMed Web of Science ®Google Scholar
• Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg. 1998;227(3):319–323.
   PubMed Web of Science ®Google Scholar
• Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum. 1991;34(10):917–920.
   PubMed Web of Science ®Google Scholar
• Chen CC, Yang SH, Lin JK, et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res. 2005;124(2):169–174.
   PubMed Web of Science ®Google Scholar
• Fakih MG, Padmanabhan A. CEA monitoring in colorectal cancer. What you should know. Oncology. 2006;20(6):579–587.
   PubMed Web of Science ®Google Scholar
• Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47(4):624–630.
   PubMed Web of Science ®Google Scholar
• Yu H, Ma L, Zhu Y, et al. Significant diagnostic value of circulating tumour cells in colorectal cancer. Oncol Lett. 2020;20(1):317–325.
   PubMed Web of Science ®Google Scholar
• Giuliano M, Shaikh A, Lo HC, et al. Perspective on circulating tumor cell clusters: why it takes a village to metastasize. Cancer Res. 2018;78(4):845–852.
   PubMed Web of Science ®Google Scholar
• Plaks V, Koopman CD, Werb Z. Cancer. Circulating tumor cells. Science. 2013;341(6151):1186–1188.
   PubMed Web of Science ®Google Scholar
• Wang FB, Yang XQ, Yang S, et al. A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients–a meta-analysis. Asian Pac J Cancer Prev. 2011;12(10):2629–2635.
   PubMedGoogle Scholar
• Gazzaniga P, Gradilone A, de Berardinis E, et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. Ann Oncol. 2012;23(9):2352–2356.
   PubMed Web of Science ®Google Scholar
• Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res. 2007;13(23):7053–7058.
   PubMed Web of Science ®Google Scholar
• Nanduri LK, Hissa B, Weitz J, et al. The prognostic role of circulating tumor cells in colorectal cancer. Expert Rev Anticancer Ther. 2019;19(12):1077–1088.
   PubMed Web of Science ®Google Scholar
• Bork U, Rahbari NN, Schölch S, et al. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer. 2015;112(8):1306–1313.
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20(7):1223–1229.
   PubMed Web of Science ®Google Scholar
• Sefrioui D, Beaussire L, Gillibert A, et al. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC). Br J Cancer. 2021;125(5):725–733.
   PubMed Web of Science ®Google Scholar
• Chu HY, Lu LS, Cho W, et al. Enumerating circulating tumor cells with a self-assembled cell array (SACA) chip: a feasibility study in patients with colorectal cancer. Cancers. 2019;11(1):56.
   PubMed Web of Science ®Google Scholar
• Aggarwal C, Meropol NJ, Punt CJ, et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol. 2013;24(2):420–428.
   PubMed Web of Science ®Google Scholar
• Chu H-Y, Yang C-Y, Yeh P-H, et al. Highly correlated recurrence prognosis in patients with metastatic colorectal cancer by synergistic consideration of circulating tumor cells/microemboli and tumor markers CEA/CA19-9. Cells. 2021;10(5):1149.
   PubMed Web of Science ®Google Scholar
• Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA. 2010;107(43):18392–18397.
   PubMed Web of Science ®Google Scholar
• Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol. 2008;19(5):935–938.
   PubMed Web of Science ®Google Scholar
• Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339(6119):580–584.
   PubMed Web of Science ®Google Scholar
• Sayagués JM, Abad MdM, Melchor HB, et al. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis. J Pathol. 2010;221(3):308–319.
   PubMed Web of Science ®Google Scholar
• Chen YY, Xu GB. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer. Med Oncol. 2014;31(12):240.
   PubMed Web of Science ®Google Scholar
• Sun B, Liu H, Wang S, et al. Prognostic impact of circulating tumor cells in patients with ampullary cancer. J Cell Physiol. 2018;233(6):5014–5022.
   PubMed Web of Science ®Google Scholar
• Ning N, Zhan T, Zhang Y, et al. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization. Clin Chim Acta. 2014;433:69–75.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li J, Jin L, et al. Independent correlation between Ki67 index and circulating tumor cells in the diagnosis of colorectal cancer. Anticancer Res. 2017;37(8):4693–4700.
   PubMed Web of Science ®Google Scholar
• Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol. 2010;2010:617421.
   PubMedGoogle Scholar
• Gorges TM, Stein A, Quidde J, et al. Improved detection of circulating tumor cells in metastatic colorectal cancer by the combination of the CellSearch® system and the AdnaTest®. PLoS One. 2016;11(5):e0155126.
   PubMed Web of Science ®Google Scholar
• Chen F, Wang S, Fang Y, et al. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application. Oncotarget. 2017;8(2):3029–3041.
   PubMed Web of Science ®Google Scholar
• Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–4470.
   PubMed Web of Science ®Google Scholar
• Abe S, Kawai K, Ishihara S, et al. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection. J Surg Res. 2016;205(2):384–392.
   PubMed Web of Science ®Google Scholar